Osteoporosis

along with practical approaches to treatment in the oldest old， Osteoporotic fractures are one of the most common and consequential diseases of advanced ageing and many antifracture therapies are widely available but largely underused. This Seminar presents an updated approach to osteoporosis consultation， and patients who continue to fracture despite therapy. Patient safety is emphasised by providing an overview of advice on safe discontinuation of denosumab in those who require it. ， fracture-risk assessment， and antiresorptive and anabolic therapies are discussed， nutrition-based therapies， those with chronic kidney disease， intervention decisions， drawing upon published evidence and collaborative expert opinion to place the data in a pragmatic and useful context for clinicians. New evidence on osteoporosis screening recommendations，。